⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited KingdomNasdaqGS

KNSA

Kiniksa Pharmaceuticals International, plc

Healthcare · Drug Manufacturers - Specialty & Generic

78.52USD

+1.4300 (+1.85%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End03/2026 Q1
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 78.52
P/E83.9
Dvd Ind Yld—
P/B10.11
P/S8.1
Curr EV/T12M EBITDA58.4
Mkt Cap (USD)6.1B
Curr EV (USD)5.5B
2)

Per Share Data

EPS T12M0.91
DPS0.00
Bk Val Per Sh8.39
Rev/Sh9.15
Cash/Sh6.74
Curr Shares Out48.3M
FCF/Sh1.99
3)

Cash Flow Analysis

P/CF36.9
Curr P/FCF37.3
CF/NI2.3
Dvd P/O0.0%
Cash Gen/Cash Reqd101.8
Csh Dvd Cov—
CFO/Sales22.0%
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr225.0%
Cap 1Y Gr29.5%
BPS 1Y Gr17.1%
R&D To Sales13.9%
Retention Rate100.0%
Rev 1Y Gr60.1%
FCF 1Y Gr436.8%
Assets 1Y Gr31.5%
5)

Profitability

EBITDA0.1B
EBIT0.1B
Operating Margin12.4%
Pretax Margin14.1%
Net Margin9.7%
ROA10.3%
ROE13.7%
ROC10.5%
Asset Turnover1.06
6)

Structure

Current Ratio3.79
Quick Ratio3.21
Debt/Assets1.1%
Debt/Com Eq1.5%
Net Debt/EBITDA-1.92
Tot Debt/Capital1.4%
Gross Margin89.3%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.